Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide

View through CrossRef
Background: forgiveness is the ability of a given regimen to maintain complete viral suppression despite a documented imperfect adherence. We explored forgiveness of bictegravir/emtricitabine/tenofovir alafenamide. Methods: drug refills were used to calculate the percent day covered (PDC) as a proxy of adherence. Forgiveness was calculated as the achieved rate of a selected HIV-RNA threshold by a given level of imperfect adherence. Results: 281 adult PLWH were followed for 343 patient/years. Adherence was very high with a median of 98% (IQR 95-100%). A PDC as low as 70% was sufficient to obtain 100% and maintain virologic suppression. According to probit analysis adherence was not related to the possibility to maintain an HIV-RNA TND or < 50 copies/ml. Conclusions: Long-term success of ART needs effective regimens that are the least intrusive of the patient's lifestyle, an elevated forgiveness may be considered as an additional feature that can further improve long-term outcomes.
Title: Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide
Description:
Background: forgiveness is the ability of a given regimen to maintain complete viral suppression despite a documented imperfect adherence.
We explored forgiveness of bictegravir/emtricitabine/tenofovir alafenamide.
Methods: drug refills were used to calculate the percent day covered (PDC) as a proxy of adherence.
Forgiveness was calculated as the achieved rate of a selected HIV-RNA threshold by a given level of imperfect adherence.
Results: 281 adult PLWH were followed for 343 patient/years.
Adherence was very high with a median of 98% (IQR 95-100%).
A PDC as low as 70% was sufficient to obtain 100% and maintain virologic suppression.
According to probit analysis adherence was not related to the possibility to maintain an HIV-RNA TND or < 50 copies/ml.
Conclusions: Long-term success of ART needs effective regimens that are the least intrusive of the patient's lifestyle, an elevated forgiveness may be considered as an additional feature that can further improve long-term outcomes.

Related Results

Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Background: Tenofovir disoproxil fumarate is a prodrug of tenofovir diphosphate that exposes patients to renal toxicity over the long term. Tenofovir alafenamide, a new prodrug, no...
The Older, the More Forgiving? Characteristics of Forgiveness of Chinese Older Adults
The Older, the More Forgiving? Characteristics of Forgiveness of Chinese Older Adults
This study explores the characteristics of forgiveness in the aging cohorts, which is regarded to be associated with healthy outcomes. Data were drawn from a sample of 308 older ad...
Forgiveness and mental Well-being: a transnational comparison
Forgiveness and mental Well-being: a transnational comparison
Purpose The purpose of this study was to investigate forgiveness and mental well-being amongst Forgiveness and mental well-being were investigated amongst British European and Nige...
Forgiveness at Work, Forgiveness at Home? Testing the Context-Dependence of Forgiveness-Related Attitudes and Values
Forgiveness at Work, Forgiveness at Home? Testing the Context-Dependence of Forgiveness-Related Attitudes and Values
Research and theory on forgiveness in the workplace draws considerably on results from the study of close relationships. This paper considers whether forgiveness-related attitudes ...

Back to Top